Abstract

Mutations in the creatine (Cr) transporter (CrT; Slc6a8) gene lead to absence of brain Cr and intellectual disabilities, loss of speech, and behavioral abnormalities. To date, no mouse model of CrT deficiency exists in which to understand and develop treatments for this condition. The purpose of this study was to generate a mouse model of human CrT deficiency. We created mice with exons 2–4 of Slc6a8 flanked by loxP sites and crossed these to Cre:CMV mice to create a line of ubiquitous CrT knockout expressing mice. Mice were tested for learning and memory deficits and assayed for Cr and neurotransmitter levels. Male CrT−/y (affected) mice lack Cr in the brain and muscle with significant reductions of Cr in other tissues including heart and testes. CrT−/y mice showed increased path length during acquisition and reversal learning in the Morris water maze. During probe trials, CrT−/y mice showed increased average distance from the platform site. CrT−/y mice showed reduced novel object recognition and conditioned fear memory compared to CrT+/y. CrT−/y mice had increased serotonin and 5-hydroxyindole acetic acid in the hippocampus and prefrontal cortex. Ubiquitous CrT knockout mice have learning and memory deficits resembling human CrT deficiency and this model should be useful in understanding this disorder.

Highlights

  • The creatine (Cr) transporter (CrT; SLC6a8) is a member of the solute carrier 6 family that transports Cr into cells in a Na+, K+dependent manner where it is used as a readily available phosphate pool to replenish ATP levels [1]

  • This suggests that CrT2/y mice have a similar biochemical phenotype compared to Creatine Transporter (CrT) deficient patients

  • CrT2/y mice show Cr reductions in muscle, which is in contrast with case reports of two CrT deficient patients who had either the presence of Cr [6] or normal Cr levels in muscle [35]

Read more

Summary

Introduction

The creatine (Cr) transporter (CrT; SLC6a8) is a member of the solute carrier 6 family that transports Cr into cells in a Na+, K+dependent manner where it is used as a readily available phosphate pool to replenish ATP levels [1]. CrT deficient patients have increased rates of epilepsy [7]. Patients have increased urinary Cr/creatinine ratios and no brain Cr peak when examined by magnetic resonance spectroscopy (MRS) [3]. Cultured fibroblasts from these patients show Cr uptake only at high levels (.500 nM) unless transfected with a functional CrT [12]. CrT deficiency is a relatively newly recognized disorder and is not routinely screened which makes estimates of the prevalence difficult to determine. Initial estimates are that it represents ,2% of all X-linked mental retardation of unknown etiology [14,15,16]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call